CardioComm Solutions’ HeartCheck™ PEN Device
The first FDA-cleared, handheld, over-the-counter ECG monitor for patient diagnosis and management
This morning we released a new Executive Informational Overview on CardioComm Solutions, Inc. (EKG-TSX.V), a company specializing in software engineering for information management systems and the integration of bio-monitoring devices for the cardiac and telemedicine markets. The full 60-page report, which details CardioComm's innovative cardiac monitoring products, market opportunities, software platforms, additional products and technologies, competition, and other key fundamentals, is available here.
About CardioComm Solutions
CardioComm's integrated electrocardiogram (ECG) and arrhythmia monitoring products and services enable patients, medical professionals, and healthcare experts to quickly and easily manage patient information and ECG recordings in a secure, reliable environment from anywhere in the world—specifically to record, view, analyze, and store patients’ ECGs for diagnosis and treatment of cardiac disorders.
Heart disease affects people of every race and geography and is not only responsible for the greatest mortality burden in the U.S., it is also the leading cause of death worldwide. According to the CDC, each year in the U.S., there are approximately 715,000 heart attacks and 795,000 strokes.
CardioComm Solutions participates in the remote patient monitoring market—a market with significant growth potential. Healthcare market research firm Kalorama Information predicts that the remote and wireless patient monitoring market could grow from $6 billion in 2011 to more than $18 billion by 2014, with an annualized growth of more than 25%.
Rated as the best enabling technology for cardiac rhythm monitoring in 2012 by Frost & Sullivan, CardioComm Solutions’ technology is used in a number of software and hardware products dedicated to improving the quality of life for anyone who has been diagnosed with, or who may be at risk for, cardiovascular disease. Roughly 50% of deaths from a heart attack happen before the patient has a chance to seek help, and strokes kill someone in the U.S. every four minutes, on average. By providing accurate, immediate cardiac data, patient monitoring technologies, such as those available from CardioComm Solutions, could increase the likelihood of individuals surviving a severe cardiac event, like a heart attack or stroke.
HeartCheck™ Product Line
The Company recently introduced a new handheld ECG recording device, the HeartCheck™ PEN ECG, which represents the first in-home, consumer-targeted health monitoring technology for over-the-counter (OTC) markets in the past 30 years. The HeartCheck™ devices (which also include a prescription HeartCheck™ Handheld ECG Monitor) are supported by software programs and patent-pending “SMART Monitoring services,” which the Company has developed to enable 24/7 patient monitoring and objective medical interpretation, with the capacity for integrating ECG reporting into existing electronic medical records (EMRs), among other innovative features. Greater details can be found in our EIO released this morning.